Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer

Radiotherapy and Oncology

Volumn 72, Issue 2, 2004, Pages 175-181

  Jereczek Fossa, Barbara A ^b   Badzio, Andrzej ^a   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Acute and late reactions; Adjuvant radiotherapy; Endometrial cancer; Quality of life; Recurrent disease; Time without tumor symptoms and toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHRONOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; INTERSTITIAL RADIATION; INTESTINE FUNCTION; KAPLAN MEIER METHOD; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RECURRENT CANCER; STATISTICAL ANALYSIS; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 3543088548     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.04.006     Document Type: Article

References (43)

1. Brown M.L., Nayfield S.G., Shibley L.M. Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment. J Natl Cancer Inst. 86:1994;424-430
2. Cardenes H., Randall M.E. Clarity and confusion regarding adjuvant radiation therapy in early endometrial cancer. Gynecol Oncol. 75:1999;1-3. editorial
3. Cole B.F., Gelber R.D., Kirkwood J.M., Goldhirsch A., Barylak E., Borden E. Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group study. J Clin Oncol. 14:1996;2666-2673
4. Cole B.F., Solal-Celigny P., Gelber R.D., et al. Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making. J Clin Oncol. 16:1998;2339-2344
5. Creutzberg C.L., van Putten W.L.J., Koper P.C.M., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre radndomised trial. Lancet. 355:2000;1404-1411
6. Creutzberg C.L., van Putten W.L.J., Koper P.C.M., et al. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys. 51:2001;1246-1255
7. Fedelstein M.L. Quality-of-life-adjusted survival for comparing cancer treatments. A commentary on TWIST and Q-TWIST. Cancer. 67:1991;851-854
8. Gelber R.D., Cole B.F., Goldhirsch A., et al. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet. 347:1996;1066-1071
9. Gelber R.D., Goldhirsch A. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol. 4:1986;1772-1779
10. Gelber R.D., Goldhirsch A., Cole B.F., Wieand H.S., Schroeder G., Krook J.E. A quality-adjusted time without symptoms or toxicity (Q-TWIST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J Natl Cancer Inst. 88:1996;1039-1045
11. Gelber R.D., Lenderking W.R., Cotton D.J., et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group. Ann Intern Med. 116:1992;961-966
12. Gilbert M., Armstrong T., Meyers C. Issues in assessing and interpreting quality of life in patients with malignant glioma. Semin Oncol. 27:2000;20-26
13. Goldhirsch A., Gelber R.D., Simes R.J., Glasziou P., Coates A.S. Cost versus benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. The Ludwig Breast Cancer Study Group. J Clin Oncol. 7:1989;36-44
14. Greven K.M., Corn B.W., Case D., Purser P., Lanciano R. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys. 39:1997;413-418
15. Greven K.M., Lanciano R.M., Herbert S.H., et al. Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation. Int J Radiat Oncol Biol Phys. 21:1991;919-923
16. Huguenin P., Baumert B., Lutolf U.M., Wight E., Glanzmann C. Curative radiotherapy in elderly patients with endometrial cancer. Patterns of relapse, toxicity and quality of life. Strahlenther Onkol. 175:1999;309-314
17. Jereczek-Fossa B.A. Postoperative irradiation in endometrial cancer: still a matter of controversy. Cancer Treat Rev. 27:2001;19-33
18. Jereczek-Fossa B., Badzio A., Jassem J. Factors determining acute normal tissue reactions during postoperative radiotherapy for endometrial cancer: analysis of consecutive 317 patients. Radiother Oncol. 68:2003;33-39
19. Jereczek-Fossa B., Badzio A., Jassem J. Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy. Int J Radiat Oncol Biol Phys. 48:2000;405-413
20. Jereczek-Fossa B., Badzio A., Jassem J. Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure. Int J Gynecol Cancer. 9:1999;285-294
21. Jereczek-Fossa B., Jassem J., Nowak R., et al. Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model. Int J Radiat Oncol Biol Phys. 41:1998;329-338
22. LENT SOMA Tables. Radiother Oncol. 35:1995;17-60
23. Levy V., Porcher R., Delabarre F., et al. Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis. J Clin Epidemiol. 54:2001;747-754
24. Macleod C., Fowler A., Duval P. Adjuvant high-dose rate brachytherapy with or without external beam radiotherapy post-hysterectomy for endometrial cancer. Int J Radiat Oncol Biol Phys. 9:1999;247-255
25. Meerwaldt J.H., Hoekstra J.M., van Putten W.L.J., et al. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors. Int J Radiat Oncol. 18:1990;299-304
26. Mounier N., Haioun C., Cole B.F., et al. Quality of life-adjusted survival analysis of high-dose therapy with autologus bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA). Blood. 95:2000;3687-3692
27. Parkin D.E., Davis J.A., Symonds R.P. Long-term bladder symptomatology following radiotherapy for cervical carcinoma. Radiother Oncol. 9:1987;195-199
28. Parsons S.K., Gelber S., Cole B.F., et al. Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: a Q-TWIST analysis of the Pediatric Oncology Group Study 8821. J Clin Oncol. 17:1999;2144-2152
29. Perez C.A., Brady L.W. Quantification of treatment toxicity. Perez C.A., Brady L.W. Principles and practice of radiation oncology. 2nd ed :1992;51-55 JB Lippincott Company, Philadelphia
30. Pignata S., Ballatori E., Favalli G., Scambia G. Quality of life: gynaecological cancers. Ann Oncol. 12:2001;S37-S42
31. Pummer K., Lehnert M., Stettner H., Hunber G. Randomized comparison of total androgen blockade alone versus combined weekly epirubicin in advanced prostate cancer. Eur Urol. 32:1997;81-85
32. Randall M.E., Wilder J., Greven K., et al. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys. 19:1990;49-54
33. Roberts J.A., Brunetto V.L., Keys H.M., et al. A phase III randomized study of surgery versus surgery plus adjunctive radiation therapy in intermediate-risk endometrial carcinoma (GOG 99) (Abstr.). Society of Gynecologic Oncologists, 99th Annual Meeting. 70:1998;1998
34. Rosendahl I., Kiebert G.M., Curran D., et al. Quality-adjusted survival (Q-TWIST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer. Prostate. 38:1999;100-109
35. Rosenthal M.A., Webster P.J., Gebski V.J., Stuart-Harris R.C., Langlands A.O., Boyages J. The cost of treating small lung cancer. Med J Aust. 156:1992;605-610
36. Scholten A.N., Creutzberg C.L., Noordijk E.M., Smit V.T. Long-term outcome in endometrial carcinoma favors a two- instead of three-tiered grading system. Int J Radiat Oncol Biol Phys. 52:2002;1067-1074
37. Schwartz C.E., Cole B.F., Vickrey B.G., Gelber R.D. The Q-TWIST approach to assessing health-related quality of life in epilepsy. Qual Life Res. 4:1995;135-141
38. Sloan J.A., Bonner J.A., Hillman S.L., et al. A quality-adjusted reanalysis of a phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 52:2002;371-381
39. Steen-Banasik E., Huls W.J.B.M., Kramer G.W.P.M., et al. Prospective study of late radiotherapeutical complications in patients with gynecological malignancies treated with external beam irradiation (Abstr.). Int J Gynecol Cancer. 9:1999;68
40. Stokes S., Bedwinek J., Breaux S., Kao M., Camel M., Perez C.A. Treatment of stage I adenocarcinoma of the endometrium by hysterectomy and irradiation: analysis of complications. Obstet Gynecol. 65:1985;86-92
41. Stryker J.A., Podczaski E., Kaminski P., et al. Adjuvant external beam therapy for pathologic stage I and occult stage II endometrial carcinoma. Cancer. 67:1991;2872-2879
42. Tai T.H.P., Yu E., Dickof P., et al. Prophylactic cranial irradiation revisited: Cost-effectiveness and quality of life in small-cell lung cancer. Int J Radiat Oncol Biol Phys. 52:2002;68-74
43. Willemse P.H., van Lith J., Mulder N.H., et al. Risk and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis. Eur J Cancer. 26:1990;345-352